Lemonaid Health vs Wellorithm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Wellorithm beats Lemonaid Health overall, scoring 7.4/10 vs 7.2/10. Wellorithm is more affordable at $147/mo vs $248/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication o. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side comparison of Lemonaid Health and Wellorithm covering pricing, scores, medication types, insurance, and more to help you decide.

Lemonaid Health

#43 of 49

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Higher Rated

Wellorithm

#30 of 49

7.4/10

Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.

Visit Wellorithm

Feature	Lemonaid Health	Wellorithm
Our Score	7.2/10	7.4/10
Starting Price	$248/mo	$147/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)	Cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers
Ranking	#43	#30

Pros & Cons Compared

Lemonaid Health

Pros

+2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately — the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

Wellorithm

Pros

+Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats — semaglutide and tirzepatide each in two formats — broader format menu than most compounded-only platforms
+10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
+Competitive entry pricing — $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
+2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
+23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment — verify on independent third-party sources before relying on it)
+Spring promotion advertised at $147 with free shipping included

Cons

−Founding year, corporate ownership, and named prescribers are NOT publicly disclosed — the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients
−49 states only — service is unavailable in Louisiana and outside the United States
−28-day recurring billing cycle with payments non-refundable once processed — strict cancellation policy and no proration for partial months
−Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
−Weight-loss guarantee terms are restrictive: requires verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval — only fees actually paid are refundable, baseline payments remain non-refundable
−Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) with different funnel structures suggest the platform tests multiple lead-capture flows, which can create inconsistent post-click experiences

Our Verdict

Wellorithm edges out Lemonaid Health with a score of 7.4/10 vs 7.2/10. If budget is your priority, Wellorithm starts at $147/mo compared to Lemonaid Health's $248/mo. Lemonaid Health offers both brand-name and compounded medications, giving you more flexibility. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Lemonaid Health nor Wellorithm feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review